ANTEOTECH ORD
AnteoTech receives first commercial order for Ultranode silicon battery from European EV maker
Queensland-based chemistry company AnteoTech (ASX: ADO) has received a $40,000 commercial order for its proprietary Ultranode 70%-silicon battery anode technology. The maiden sale came from a European electric vehicle manufacturer (known as EV1) that has been trialling the product to assess its performance-enhancing characteristics. The ongoing trial will be carried out in parallel with EV1’s […]
AnteoTech unveils rapid and more accurate proof of concept COVID-19 test
Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multiplex test platform that can detect whether patients have been, or are currently, infected with the coronavirus. The dual […]
AnteoTech signs agreement with Merck to co-develop products for global point-of-care market
Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck KGaA to co-develop products for the world’s rapidly-growing point of care diagnostic testing market. The products will harness Merck’s full range of europium particles activated with AnteoBind to offer an advanced toolset for assay […]
AnteoTech partners with US company to develop point-of-care products using AnteoBind coatings
Chemistry and coating company AnteoTech (ASX: ADO) has signed a commercial agreement with IMRA America Inc for the joint development of AnteoBind-coated gold particles to be used in point-of-care diagnostics. Under the agreement, AnteoTech (formerly known as Anteo Diagnostics) will activate IMRA’s i-colloid gold particles with AnteoBind. The combined product will be branded and marketed […]